由于维生素价格波动加剧，帝斯曼芬美意计划将动物营养和健康业务分开。 DSM-Firmenich plans to separate animal nutrition and health business amid rising vitamin price volatility.

帝斯曼芬美意公布了跑赢大市的盈利报告，并宣布计划分拆其动物营养和健康业务，该公司股价上涨。 DSM-Firmenich shares rose after the company reported market-beating earnings and announced plans to separate its animal nutrition and health business. 该公司认为，ANH 业务的全部潜力可以通过不同的所有权结构来实现，并考虑所有潜在的分离方案。 The company believes that the full potential of the ANH business could be realized through a different ownership structure, with all potential separation options being considered. 此次分离的目的是在动物市场维生素价格面临前所未有的周期性压力后，减少维生素收入波动和资本密集度的风险。 The separation aims to reduce exposure to vitamins earnings volatility and capital intensity following unprecedented cyclical pressure on vitamin prices in the animal markets.